ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,327,998 | -20.7% | 384,793 | +1.7% | 0.69% | -15.8% |
| Q2 2023 | $2,935,003 | -6.7% | 378,222 | -31.5% | 0.82% | -15.0% |
| Q1 2023 | $3,144,969 | -4.2% | 551,749 | -1.0% | 0.96% | -2.7% |
| Q4 2022 | $3,283,263 | +200.7% | 557,430 | +63.4% | 0.99% | +136.5% |
| Q3 2022 | $1,092,000 | -33.2% | 341,182 | -6.5% | 0.42% | -41.1% |
| Q2 2022 | $1,634,000 | – | 364,741 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |